Tech Company Financing Transactions
Verax Biomedical Funding Round
BioVentures Investors and SightLine Partners participated in a $3.5 million funding round for Verax Biomedical. The round closed on 3/31/2010.
Transaction Overview
Company Name
Announced On
3/31/2010
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Undisclosed
Investors
SightLine Partners (Buzz Benson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
148 Bartlett St.
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Lousararian
VP - Bus. Development
Joe Sanders
VP - Finance
Paul Ragusa
VP - Operations
Scott McKenzie
VP - R & D
Yli Vallejo
VP - Regulatory Affairs
Nancy Hornbaker
Browse more venture capital transactions:
Prev: 3/31/2010: Sustainable Real Estate Solutions venture capital transaction
Next: 3/31/2010: Nexxo Financial venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs